252 related articles for article (PubMed ID: 31892490)
1. Salvage Focal Cryotherapy Offers Similar Short-term Oncologic Control and Improved Urinary Function Compared With Salvage Whole Gland Cryotherapy for Radiation-resistant or Recurrent Prostate Cancer.
Tan WP; ElShafei A; Aminsharifi A; Khalifa AO; Polascik TJ
Clin Genitourin Cancer; 2020 Jun; 18(3):e260-e265. PubMed ID: 31892490
[TBL] [Abstract][Full Text] [Related]
2. Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy.
de Castro Abreu AL; Bahn D; Leslie S; Shoji S; Silverman P; Desai MM; Gill IS; Ukimura O
BJU Int; 2013 Aug; 112(3):298-307. PubMed ID: 23826840
[TBL] [Abstract][Full Text] [Related]
3. Disease-free survival following salvage cryotherapy for biopsy-proven radio-recurrent prostate cancer.
Williams AK; Martínez CH; Lu C; Ng CK; Pautler SE; Chin JL
Eur Urol; 2011 Sep; 60(3):405-10. PubMed ID: 21185115
[TBL] [Abstract][Full Text] [Related]
4. Salvage Prostate Cryoablation for the Management of Local Recurrence After Primary Cryotherapy: A Retrospective Analysis of Functional and Intermediate-Term Oncological Outcomes Associated With a Second Therapeutic Freeze.
Aminsharifi A; Jibara G; Tsivian E; Tsivian M; Elshafei A; Polascik TJ
Clin Genitourin Cancer; 2019 Aug; 17(4):e831-e836. PubMed ID: 31213413
[TBL] [Abstract][Full Text] [Related]
5. Salvage Cryoablation for Recurrent Prostate Cancer Following Primary External Beam Radiotherapy or Primary Cryotherapy: A Propensity Score Matched Analysis of Mid-term Oncologic and Functional Outcomes.
Campbell SP; Deivasigamani S; Arcot R; Adams ES; Orabi H; Elshafei A; Tan WP; Davis L; Wu Y; Chang A; Jones JS; Polascik TJ
Clin Genitourin Cancer; 2023 Oct; 21(5):555-562. PubMed ID: 37438234
[TBL] [Abstract][Full Text] [Related]
6. Intermediate-term oncological and functional outcomes of salvage cryotherapy for the management of prostate cancer recurrence after primary brachytherapy versus primary cryotherapy: A propensity score-matched analysis.
Deivasigamani S; Orabi H; El-Shafei A; Adams ES; Kotamarti S; Aminsharifi A; Davis L; Wu Y; J SJ; Polascik TJ
Prostate; 2023 Oct; 83(14):1373-1386. PubMed ID: 37469120
[TBL] [Abstract][Full Text] [Related]
7. Salvage focal prostate cryoablation for locally recurrent prostate cancer after radiotherapy: initial results from the cryo on-line data registry.
Li YH; Elshafei A; Agarwal G; Ruckle H; Powsang J; Jones JS
Prostate; 2015 Jan; 75(1):1-7. PubMed ID: 25283814
[TBL] [Abstract][Full Text] [Related]
8. Salvage cryotherapy with third-generation technology for locally recurrent prostate cancer after radiation therapy.
Lian H; Yang R; Lin T; Wang W; Zhang G; Guo H
Int Urol Nephrol; 2016 Sep; 48(9):1461-6. PubMed ID: 27300004
[TBL] [Abstract][Full Text] [Related]
9. Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy.
Spiess PE; Lee AK; Leibovici D; Wang X; Do KA; Pisters LL
Cancer; 2006 Jul; 107(2):275-80. PubMed ID: 16770783
[TBL] [Abstract][Full Text] [Related]
10. Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy.
Pisters LL; Leibovici D; Blute M; Zincke H; Sebo TJ; Slezak JM; Izawa J; Ward JF; Scott SM; Madsen L; Spiess PE; Leibovich BC
J Urol; 2009 Aug; 182(2):517-25; discussion 525-7. PubMed ID: 19524984
[TBL] [Abstract][Full Text] [Related]
11. Salvage focal cryosurgery may delay use of androgen deprivation therapy in cryotherapy and radiation recurrent prostate cancer patients.
Kongnyuy M; Berg CJ; Kosinski KE; Habibian DJ; Schiff JT; Corcoran AT; Katz AE
Int J Hyperthermia; 2017 Nov; 33(7):810-813. PubMed ID: 28540788
[TBL] [Abstract][Full Text] [Related]
12. Operative and Midterm Oncological Outcome of Focal Salvage Cryotherapy for Localized Prostate Cancer.
Vestris PG; Giwerc A; Hennequin C; Goujon A; Meria P; Verine J; Desgrandchamps F; de Kerviler E; Mongiat-Artus P; Masson-Lecomte A
Urol Int; 2022; 106(9):897-902. PubMed ID: 34781287
[TBL] [Abstract][Full Text] [Related]
13. Achieving the 'bifecta' using salvage cryotherapy for locally recurrent prostate cancer: analysis of the Cryo On-Line Data (COLD) registry data.
Spiess PE; Given RW; Jones JS
BJU Int; 2012 Jul; 110(2):217-20. PubMed ID: 21992443
[TBL] [Abstract][Full Text] [Related]
14. Comparative Effectiveness Analyses of Salvage Prostatectomy and Salvage Radiotherapy Outcomes Following Focal or Whole-Gland Ablative Therapy (High-Intensity Focused Ultrasound, Cryotherapy or Electroporation) for Localised Prostate Cancer.
Nathan A; Ng A; Mitra A; Sooriakumaran P; Davda R; Patel S; Fricker M; Kelly J; Shaw G; Rajan P; Sridhar A; Nathan S; Payne H
Clin Oncol (R Coll Radiol); 2022 Jan; 34(1):e69-e78. PubMed ID: 34740477
[TBL] [Abstract][Full Text] [Related]
15. Third-generation salvage cryotherapy for radiorecurrent prostate cancer: a centre's experience.
Philippou P; Yap T; Chinegwundoh F
Urol Int; 2012; 88(2):137-44. PubMed ID: 22285952
[TBL] [Abstract][Full Text] [Related]
16. Salvage cryotherapy for local recurrence after radiotherapy for prostate cancer.
Kvorning Ternov K; Krag Jakobsen A; Bratt O; Ahlgren G
Scand J Urol; 2015 Apr; 49(2):115-9. PubMed ID: 25428754
[TBL] [Abstract][Full Text] [Related]
17. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Outcomes of Whole Gland Salvage Cryotherapy for Locally Recurrent Prostate Cancer following Radiation Therapy: A Combined Analysis of Two Centers.
Chin JL; Lavi A; Metcalfe MJ; Siddiqui K; Dewar M; Petros FG; Li R; Nogueras González GM; Wang X; Nair SM; Ward JF; Pisters L
J Urol; 2021 Sep; 206(3):646-654. PubMed ID: 33908799
[TBL] [Abstract][Full Text] [Related]
19. Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years.
Bahn D; de Castro Abreu AL; Gill IS; Hung AJ; Silverman P; Gross ME; Lieskovsky G; Ukimura O
Eur Urol; 2012 Jul; 62(1):55-63. PubMed ID: 22445223
[TBL] [Abstract][Full Text] [Related]
20. Propensity Score-Matched Comparison of Partial to Whole-Gland Cryotherapy for Intermediate-Risk Prostate Cancer: An Analysis of the Cryo On-Line Data Registry Data.
Tay KJ; Polascik TJ; Elshafei A; Tsivian E; Jones JS
J Endourol; 2017 Jun; 31(6):564-571. PubMed ID: 28385075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
